top of page

NCT01042379

I-SPY TRIAL: Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2.


This research study aims to predict how well different cancer treatments will work for individual patients. They do this by using advanced imaging techniques and analyzing the patient's cancer cells at a molecular level. By understanding these details, doctors hope to better predict how patients will respond to different treatments, leading to more effective and personalized care.


For more information about the trial, click the link below:

Clinical Trial Site: Einstein/Columbia


To see all available clinical trials click here.



Recent Posts

See All

NCI-2023-00614

A Phase 3 Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Versus Investigator's Choice of...

NCI-2021-00222

NRG-BR007: A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone...

NCI-2023-06503

An open-label, single-arm, Phase 1b/2 study to investigate the safety, efficacy and pharmacokinetics of LS301-IT in female patients...

Kommentare


bottom of page